Concepedia

Amit Roy

AR

Statistics

Publications

64

Citations

3.3K

H-Index

30

Active since

1995

Affiliations

Bristol-Myers Squibb (United States)(Current)

Environmental and Occupational Health Sciences Institute

Bristol-Myers Squibb (Germany)

Bristol-Myers Squibb (Sweden)

Rutgers, The State University of New Jersey

Amit Roy is an author at Bristol-Myers Squibb (United States) specializing in pharmacy, pharmacology, and pharmacokinetics.

ORCID

Publications per year

1995–2024

64

Publications

64

Model-Based Population Pharmacokinetic Analysis of Nivolumab in Patients With Solid Tumors

Gaurav Bajaj, Xueyan Wang, Sachin Agrawal et al. · CPT Pharmacometrics & Systems Pharmacology · 2016 · 252 citations · Full text

, , +15

Assessment of nivolumab benefit–risk profile of a 240-mg flat dose relative to a 3-mg/kg dosing regimen in patients with advanced tumors

Xiaochen Zhao, Satyendra Suryawanshi, Matthew Hruska et al. · Annals of Oncology · 2017 · 235 citations · Full text

, , +17

Nivolumab dose selection: challenges, opportunities, and lessons learned for cancer immunotherapy

Shruti Agrawal, Feng Yan, Amit Roy et al. · Journal for ImmunoTherapy of Cancer · 2016 · 212 citations · Full text

, , +17

Innovative Approaches for Designing and Analyzing Adaptive Dose-Ranging Trials

Björn Bornkamp, Frank Bretz, Alex Dmitrienko et al. · Journal of Biopharmaceutical Statistics · 2007 · 193 citations

, , +15

Measurement of children's exposure to pesticides: analysis of urinary metabolite levels in a probability-based sample.

John L. Adgate, Dana Boyd Barr, C. Andrew Clayton et al. · Environmental Health Perspectives · 2001 · 185 citations · Full text

, , +17

1–5 of 64